Getting a prescription for wegovy (semaglutide) isn't as simple as just asking your doctor for it. It's a powerful medication approved for chronic weight management, and healthcare providers follow strict, evidence-based criteria to ensure it's prescribed safely and appropriately to the patients who are most likely to benefit. The typical requirements generally fall into three main categories: meeting specific body mass index (BMI) thresholds, having a weight-related health condition, and demonstrating a commitment to lifestyle changes. Furthermore, you'll need to navigate insurance coverage, which has its own set of hurdles. Let's break down each of these requirements in detail.
Meeting the Body Mass Index (BMI) Criteria
The most fundamental requirement is based on your Body Mass Index, which is a measure of body fat based on height and weight. The U.S. Food and Drug Administration (FDA) approval is very clear on this point. You will typically qualify for a wegovy prescription under one of two BMI scenarios:
- BMI of 30 or higher: This classifies as obesity.
- BMI of 27 or higher: This classifies as overweight, but you must also have at least one weight-related comorbid condition.
It's crucial to understand that these aren't just arbitrary numbers. A BMI of 30, for example, means a person who is 5'9" tall would weigh 203 pounds or more. This threshold is significant because it marks the point where the health risks associated with excess weight increase substantially. Your doctor will calculate your BMI during your appointment, but you can get a general idea using online calculators. It's also important to note that BMI is a screening tool, not a diagnostic one. A healthcare provider will consider other factors like muscle mass, but it remains the primary gateway for prescription eligibility.
| Height | Weight for BMI 27 (Overweight) | Weight for BMI 30 (Obesity) |
|---|---|---|
| 5' 5" | 162 lbs (73.5 kg) | 180 lbs (81.6 kg) |
| 5' 9" | 182 lbs (82.5 kg) | 203 lbs (92.1 kg) |
| 6' 0" | 199 lbs (90.3 kg) | 221 lbs (100.2 kg) |
Having a Weight-Related Comorbidity
If your BMI falls in the 27-29.9 range, the prescription hinges on having at least one serious health condition exacerbated by your weight. This is because the benefits of the medication in reducing health risks are considered to outweigh the potential side effects. The key comorbid conditions recognized by the FDA and most insurance companies include:
- Type 2 Diabetes: This is a major one. Wegovy not only aids weight loss but also improves blood sugar control.
- Hypertension (High Blood Pressure): Even a modest weight reduction of 5-10% can significantly lower blood pressure.
- Dyslipidemia (High Cholesterol): This includes high levels of LDL ("bad") cholesterol or triglycerides.
- Obstructive Sleep Apnea: A condition where breathing repeatedly stops and starts during sleep, closely linked to obesity.
- Cardiovascular Disease: Such as a history of heart attack or stroke.
Your doctor will need documented evidence of these conditions, usually from your medical history, recent blood tests, or a sleep study. Simply stating you have high blood pressure isn't enough; they'll need to see the readings in your chart. The presence of these conditions demonstrates that your weight is not just a cosmetic concern but a central factor in your overall health profile.
The Crucial Role of a Comprehensive Weight Management Program
Perhaps the most overlooked requirement is the commitment to a concurrent lifestyle intervention program. The FDA approval for wegovy explicitly states it is indicated "as an adjunct to a reduced-calorie diet and increased physical activity." In plain English, this means the medication is a tool to support your efforts, not a magic solution that works on its own.
A responsible prescriber will want to see that you have already attempted to lose weight through diet and exercise. They will also expect you to continue these efforts while on the medication. This often involves working with a dietitian to create a sustainable, reduced-calorie meal plan and developing an exercise routine that you can stick with, even if it's just walking 30 minutes a day. The medication works by mimicking a hormone called GLP-1 that targets areas of the brain that regulate appetite and food intake, making it easier to stick to those healthier choices. But if you don't make the choices, the medication's effectiveness is severely limited. Doctors are looking for a partnership, not a passive patient.
Navigating Insurance and Cost Barriers
This is where many people hit a wall. Even if you meet all the clinical criteria, your insurance plan may not cover wegovy, or they may have requirements that are even stricter than the FDA's. Weight loss medications are often classified as "lifestyle drugs" by insurers and are subject to complex prior authorization processes.
Here’s what you can expect when dealing with insurance:
- Prior Authorization (PA): This is a process where your doctor must submit documentation to your insurance company proving you meet their specific criteria. This often includes proof of BMI, records of comorbid conditions, and sometimes even proof of participation in a formal weight management program for a certain period (e.g., 3-6 months).
- Step Therapy: Many plans require you to try and fail on cheaper, often older, weight-loss medications before they will approve wegovy. This might mean trying phentermine or orlistat first.
- High Out-of-Pocket Cost: If your insurance doesn't cover it, the list price for a month's supply of wegovy is over $1,300. Manufacturer savings cards can help reduce this cost for eligible patients, but it's still a significant financial commitment.
It's essential to contact your insurance provider directly or work with your pharmacist to understand your plan's specific "pharmacy benefits" for weight management agents. The clinical criteria are only half the battle; the financial and administrative hurdles are equally important to understand from the start.
Contraindications: When You Might Not Be a Candidate
Finally, there are specific medical situations where wegovy is contraindicated, meaning your doctor should not prescribe it due to safety concerns. Being aware of these is just as important as knowing the eligibility requirements. The most critical contraindications include:
- Personal or Family History of Medullary Thyroid Carcinoma (MTC): Or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is a black box warning, the FDA's strongest safety alert, because rodent studies showed a risk of thyroid tumors. It is unknown if this risk applies to humans, but it is taken very seriously.
- Pregnancy, Breastfeeding, or Planning Pregnancy: The effects on a fetus are unknown, so it is not recommended for use during pregnancy. Women of childbearing age should use effective contraception while taking the medication.
- Severe Gastrointestinal Disease: Including gastroparesis (delayed stomach emptying), as wegovy commonly causes nausea, vomiting, and diarrhea, which could exacerbate these conditions.
- Pancreatitis: A history of pancreatitis is a reason for caution, as GLP-1 receptor agonists have been associated with a risk of inflammation of the pancreas.
- Allergy: A known hypersensitivity to semaglutide or any of the ingredients in the formulation.
Your doctor will conduct a thorough medical history review to screen for these conditions before even considering a prescription. Full transparency with your healthcare provider about your entire medical and family history is absolutely vital for your safety.
The journey to getting a wegovy prescription is a structured one, designed to prioritize patient safety and maximize the chances of successful, sustainable weight loss. It involves a collaborative relationship with your healthcare team, a clear understanding of the clinical benchmarks, and patience to navigate the healthcare system. If you believe you meet these criteria, the next step is to schedule a candid conversation with a knowledgeable healthcare provider to discuss your goals and medical history in depth.